Search
for
Sort by
Research 121–150 of 130
- Trans-Epidermal Elimination Due to Insulin Formulation: Report of a Rare Adverse Effect
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- 5α-Reductases In Human Physiology: an Unfolding Story
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Contact Dermatitis Caused by Topical Minoxidil: Allergy or Just Irritation
- Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- 5α-Reductases in Human Physiology: An Unfolding Story
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Reactions to Drugs
- Cutaneous drug reactions
- Pediatric Inpatients Requesting Dermatology Consultation in a Tertiary Care Hospital: Retrospective Analysis of 614 Patients
- Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
- Adverse Cutaneous Reactions to Antipsychotics
- Psychoactive drugs and skin
- Drug eruptions in dermatology
- Drug-Induced Skin, Nail and Hair Disorders
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Mucocutaneous reactions to chemotherapy
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Maculopapular Drug Eruption Caused by Finasteride: A Case Report
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Dermatological Manifestations of COVID-19: A Brief Review
- Severe cutaneous adverse reactions to drugs
- Confirmation of Metformin-Induced Acute Generalized Exanthematous Pustulosis Through a Positive Dechallenge-Rechallenge Test: A Case Report and Review of Cutaneous Manifestations Associated With Metformin